Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL).
Paul BuderathTra My DangRainer KimmigPublished in: Journal of gynecologic oncology (2024)
Our results confirm the feasibility and safety of PMMR+TCL in EC patients. Oncologic data are very encouraging and hint at a superior locoregional control without adjuvant irradiation. Larger studies with longer follow-up will be needed to confirm these results.
Keyphrases
- endometrial cancer
- minimally invasive
- end stage renal disease
- early stage
- robot assisted
- ejection fraction
- chronic kidney disease
- newly diagnosed
- papillary thyroid
- prognostic factors
- lymph node metastasis
- electronic health record
- coronary artery bypass
- coronary artery disease
- squamous cell
- radiation induced
- surgical site infection
- drug delivery
- case control